Outcome After Surgical Treatments
- Total resection curative: Cure is expected in the majority of children who are operated early in the disease process, especially when the tumor diameter is less than 3 cm.
- Subtotal resection: Surgery may need to stop short of complete resection when there is extensive disease or excessive bleeding.
Outcome After Nonsurgical Treatments
Other treatment options include medications and radiosurgery therapy.
- Rapamycin: A modest response to rapamycin has been documented, but further clinical trials are needed to address the outcome.
- Everolimus: A phase II trial using everolimus, another mTor inhibitor used as an anti-organ rejection drug, to treat SEGAs in 28 patients with TSC showed SEGA reduction of at least 30% in 21 patients (75%) and at least 50% in 9 patients (32%) (19).
- mTOR agents inhibit growth but don’t cure: There is clear evidence that SEGAs grow back after the mTOR inhibitor is stopped (11). Most experts currently recommend continuation of mTOR inhibitors at the lowest efficacious dose.
Please create a free account or log in to read 'Outcome of Treatments for Subependymal Giant Cell Astrocytomas in Children'
Registration is free, quick and easy. Register and complete your profile and get access to the following:
- Full unrestricted access to The ISPN Guide
- Download pages as PDFs for offline viewing
- Create and manage page bookmarks
- Access to new and improved on-page references
